haes, I.D.; Dendooven, A.; Mercier, M.L.; Puylaert, P.; Vermeulen, K.; Kockx, M.; Deiteren, K.; Maes, M.-B.; Berneman, Z.; Anguille, S.
Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics. J. Clin. Med. 2020, 9, 3090.
https://doi.org/10.3390/jcm9103090
AMA Style
haes ID, Dendooven A, Mercier ML, Puylaert P, Vermeulen K, Kockx M, Deiteren K, Maes M-B, Berneman Z, Anguille S.
Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics. Journal of Clinical Medicine. 2020; 9(10):3090.
https://doi.org/10.3390/jcm9103090
Chicago/Turabian Style
haes, Inke De, Amélie Dendooven, Marie Le Mercier, Pauline Puylaert, Katrien Vermeulen, Mark Kockx, Kathleen Deiteren, Marie-Berthe Maes, Zwi Berneman, and Sébastien Anguille.
2020. "Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics" Journal of Clinical Medicine 9, no. 10: 3090.
https://doi.org/10.3390/jcm9103090
APA Style
haes, I. D., Dendooven, A., Mercier, M. L., Puylaert, P., Vermeulen, K., Kockx, M., Deiteren, K., Maes, M. -B., Berneman, Z., & Anguille, S.
(2020). Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics. Journal of Clinical Medicine, 9(10), 3090.
https://doi.org/10.3390/jcm9103090
